Published in Arch Surg on June 01, 2009
Hepatic portal venous gas--three non-fatal cases and review of the literature. Ulster Med J (2012) 1.54
Acute gastric dilatation: a transient cause of hepatic portal venous gas-case report and review of the literature. Case Rep Gastrointest Med (2013) 1.05
Portal venous gas: is it a premorbid indicator? BMJ Case Rep (2011) 1.01
Retraction-related liver lobe necrosis after laparoscopic gastric surgery. JSLS (2011) 0.98
Clinical outcomes in surgical and non-surgical management of hepatic portal venous gas. Korean J Hepatobiliary Pancreat Surg (2015) 0.96
A case of hepatic portal venous gas as a complication of endoscopic balloon dilatation. J Korean Med Sci (2011) 0.95
Risk factors for bowel necrosis in patients with hepatic portal venous gas. Surg Today (2014) 0.91
Extraordinary cause of acute gastric dilatation and hepatic portal venous gas: Chronic use of synthetic cannabinoid. World J Gastroenterol (2015) 0.90
Computed tomography findings of pneumatosis and portomesenteric venous gas in acute bowel ischemia. World J Gastroenterol (2013) 0.89
Conservative treatment of hepatic portal venous gas consecutive to a complicated diverticulitis: A case report and literature review. Int J Surg Case Rep (2016) 0.87
Postoperative pneumatosis intestinalis (PI) and portal venous gas (PVG) may indicate bowel necrosis: a 52-case study. BMC Surg (2016) 0.85
Enterovenous fistulization: a rare complication of Crohn's disease. World J Gastroenterol (2011) 0.85
Transient extensive hepatic portal venous gas following hypotension in a dialysis patient. BMJ Case Rep (2013) 0.82
A rare case report of spontaneous resolution of hepatic portal venous gas associated with cocaine-induced intestinal ischemia. Ann Med Health Sci Res (2015) 0.81
A rare case of ischaemic pneumatosis intestinalis and hepatic portal venous gas in an elderly patient with good outcome following conservative management. Int J Surg Case Rep (2016) 0.81
Clinical significance of pneumatosis intestinalis - correlation of MDCT-findings with treatment and outcome. Eur Radiol (2016) 0.81
Delayed intestinal stricture following non-resectional treatment for non-occlusive mesenteric ischemia associated with hepatic portal venous gas: a case report. BMC Surg (2015) 0.79
Hepatic portal venous gas in Crohn's disease. BMJ Case Rep (2014) 0.78
Hepatic portal venous gas and portal venous thrombosis following colonoscopy in a patient with terminal ileal Crohn's disease. BMJ Case Rep (2015) 0.77
"STOP, LOOK, and LISTEN." Hepatic Portal Venous Gas: Time for Clinical Assessment! Int J Angiol (2013) 0.77
Symptomatic pneumatosis intestinalis (including portal venous gas) after laparoscopic total colectomy. World J Gastrointest Endosc (2014) 0.77
Hepatic portal venous gas: comparison of two cases. Case Rep Surg (2013) 0.77
Hepatic portal venous gas after endoscopy in a patient with anastomotic obstruction. World J Gastrointest Surg (2015) 0.77
Unusual radiological finding of lethal pneumatosis intestinalis and portomesenteric vein gas. World J Radiol (2010) 0.75
Extensive portal venous gas in a post-operative patient with no identifiable cause. J Surg Case Rep (2015) 0.75
Gastric Occlusion Due to Intragastric Balloon with Gastric Necrosis and Portal Pneumatosis. ACG Case Rep J (2016) 0.75
Asymptomatic hepatic portal venous gas with gastric emphysema as a chronic complication of gastrostomy tube placement: a case report. J Med Case Rep (2016) 0.75
Dobutamine stress echocardiography resulting in acute gastric dilatation and pneumoporta. Ann R Coll Surg Engl (2016) 0.75
Air in the portal vein: where computed tomography saved a patient's life. Oxf Med Case Reports (2017) 0.75
A Case of Hepatic Portal Venous Gas: Hypothesis of a Transient Direct Communication between a Penetrating Antral Gastric Ulcer and Mesenteric Varices. Case Rep Gastrointest Med (2017) 0.75
Extensive portal venous gas: Unlikely etiology and outcome. Int J Surg Case Rep (2014) 0.75
Bilateral Emphysematous Pyelonephritis with Hepatic Portal Venous Gas: Case Report. Malays J Med Sci (2015) 0.75
Careful approach to the ABCs of the management of portal venous gas. Arch Surg (2010) 0.75
Neobladder Obstruction: A Non-ischemic Cause for Hepatic Portal Venous Gas: Case Report. Urol Case Rep (2017) 0.75
Portal venous gas and pneumatosis intestinalis. Rare radiological signs in a rare complication of Meckel's diverticulum. J Surg Case Rep (2010) 0.75
Smoke trails of a dying gut: portal and mesenteric vein gas. BMJ Case Rep (2010) 0.75
Mesenteric ischaemia with massive hepatic portal venous gas. BMJ Case Rep (2013) 0.75
Gas in Hepatic Portal Veins with Gastric Massive Dilatation and Pneumatosis in Acute Pancreatitis. J Clin Diagn Res (2015) 0.75
Role of Computed tomography in predicting prognosis of Hepatic portal venous gas. Int J Surg Case Rep (2016) 0.75
Hepatic portal venous gas: findings on ultrasound and CT. West J Emerg Med (2014) 0.75
Hepatic Portal Venous Gas in Children Younger Than 2 Years Old - Radiological and Clinical Characteristics in Diseases Other Than Necrotizing Enterocolitis. Pol J Radiol (2017) 0.75
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature (2003) 10.33
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet (2006) 8.32
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42
Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell (2009) 7.39
Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med (2010) 7.11
Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology (2004) 6.75
3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging (2012) 6.36
Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med (2010) 5.59
Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis (2002) 5.34
Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg (2004) 5.09
Autoimmune pancreatitis. N Engl J Med (2006) 5.00
Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg (2003) 4.86
A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell (2012) 4.49
Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum (2012) 4.27
A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe (2009) 4.24
Cystic neoplasms of the pancreas. N Engl J Med (2004) 3.89
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery (2012) 3.87
Development trends for therapeutic antibody fragments. Nat Biotechnol (2009) 3.51
In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia. Gastroenterology (2007) 3.41
Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Invest (2003) 3.40
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol (2006) 3.37
Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients. Hepatology (2008) 3.14
Comparison and evaluation of methods for liver segmentation from CT datasets. IEEE Trans Med Imaging (2009) 3.03
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology (2007) 2.96
High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology (2004) 2.91
Right-liver living donor transplantation for decompensated end-stage liver disease. Liver Transpl (2002) 2.86
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Ann Surg (2015) 2.79
CD8 epitope escape and reversion in acute HCV infection. J Exp Med (2004) 2.77
HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med (2002) 2.69
Case records of the Massachusetts General Hospital. Case 23-2005. A 57-year-old man with a mass in the liver. N Engl J Med (2005) 2.67
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol (2005) 2.63
The impact of the 80-hour resident workweek on surgical residents and attending surgeons. Ann Surg (2006) 2.59
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg (2008) 2.45
Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology (2008) 2.45
STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. Cancer Res (2011) 2.35
Autoimmune pancreatitis: imaging features. Radiology (2004) 2.34
The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C. Liver Int (2009) 2.33
Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg (2005) 2.27
Development of an accurate index for predicting outcomes of patients with acute liver failure. Gastroenterology (2012) 2.26
Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection? Ann Surg (2013) 2.26
American Surgical Association Blue Ribbon Committee Report on Surgical Education: 2004. Ann Surg (2005) 2.25
Implications and cost of pancreatic leak following distal pancreatic resection. Arch Surg (2006) 2.25
Incidental pancreatic cysts: do we really know what we are watching? Pancreatology (2010) 2.22
In-vivo interaction of nitric oxide and endothelin. J Hypertens (2004) 2.20
Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up. Hepatology (2009) 2.13
Viral sequence evolution in acute hepatitis C virus infection. J Virol (2007) 2.13
Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology (2013) 2.13
A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Gastroenterology (2011) 2.08
Identification of surgical complications and deaths: an assessment of the traditional surgical morbidity and mortality conference compared with the American College of Surgeons-National Surgical Quality Improvement Program. J Am Coll Surg (2006) 2.07
Plectin-1 as a novel biomarker for pancreatic cancer. Clin Cancer Res (2010) 2.03
Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J Virol (2002) 2.03
Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem (2005) 2.02
Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood (2008) 2.01
High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome. J Virol (2007) 2.01
Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol (2002) 1.98
Residency training in surgery in the 21st century: a new paradigm. Surgery (2004) 1.94
Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA (2008) 1.94
Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut (2011) 1.94
Monitoring of putative vectors of bluetongue virus serotype 8, Germany. Emerg Infect Dis (2009) 1.92
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol (2009) 1.90
Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J Virol (2006) 1.87
Hepatitis C virus expression suppresses interferon signaling by degrading STAT1. Gastroenterology (2005) 1.87
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med (2013) 1.82
Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial. Gastroenterology (2009) 1.80
Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia. Gastroenterology (2009) 1.78
Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes. Arch Surg (2011) 1.78
Coinfection with HIV-1 and HCV--a one-two punch. Gastroenterology (2009) 1.78
Liver transplantation for erythropoietic protoporphyria liver disease. Liver Transpl (2005) 1.76
Imaging angiogenesis: applications and potential for drug development. J Natl Cancer Inst (2005) 1.76
Influence of high body mass index on outcome in acute liver failure. Clin Gastroenterol Hepatol (2006) 1.74
Non-high-density lipoprotein cholesterol as a biomarker for nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol (2012) 1.74
Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C. Gastroenterology (2006) 1.73
Implications and management of pancreatic fistulas following pancreaticoduodenectomy: the Massachusetts General Hospital experience. Arch Surg (2008) 1.72
DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial. J Hepatol (2008) 1.71
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial. Clin Gastroenterol Hepatol (2007) 1.71
Debridement and closed packing for sterile or infected necrotizing pancreatitis: insights into indications and outcomes in 167 patients. Ann Surg (2008) 1.69
851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital. Surgery (2012) 1.68
Spontaneous resolution of chronic hepatitis C virus disease after withdrawal of immunosuppression. Gastroenterology (2003) 1.68
Current trends in pancreatic cystic neoplasms. Arch Surg (2009) 1.68
Neutrophil metabolic activity but not neutrophil sequestration reflects the development of pancreatitis-associated lung injury. Crit Care Med (2002) 1.67
Air trapping and airflow obstruction in newborn cystic fibrosis piglets. Am J Respir Crit Care Med (2013) 1.65
IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway. J Hepatol (2010) 1.64
GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. J Infect Dis (2006) 1.64
HIV increases HCV replication in a TGF-beta1-dependent manner. Gastroenterology (2008) 1.60
Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol (2005) 1.59
Gc-globulin and prognosis in acute liver failure. Liver Transpl (2005) 1.59
Automated 3-D segmentation of lungs with lung cancer in CT data using a novel robust active shape model approach. IEEE Trans Med Imaging (2011) 1.59
Standardized evaluation methodology and reference database for evaluating coronary artery centerline extraction algorithms. Med Image Anal (2009) 1.58
Gastrointestinal complications in patients undergoing heart operation: an analysis of 8709 consecutive cardiac surgical patients. Ann Surg (2005) 1.57
Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy. J Virol (2005) 1.54
The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1. Blood (2004) 1.53
Communication practices on 4 Harvard surgical services: a surgical safety collaborative. Ann Surg (2009) 1.53
Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system. J Virol (2002) 1.52
Chronic cyclooxygenase-2 inhibition does not alter blood pressure and kidney function in renovascular hypertensive rats. J Hypertens (2004) 1.51
Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner. Gastroenterology (2010) 1.51
Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes. Gastroenterology (2010) 1.51